Alnylam Pharmaceuticals (ALNY)

Earnings in 2024 (TTM): -€0.17 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings are €2.09 Billion. In 2023 the company made an earning of -€0.3 Billion, an increase over its 2022 earnings that were of -€0.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alnylam Pharmaceuticals from 2003 to 2024

Annual earnings

Year	Earnings	Change
2024 (TTM)	-€0.17 Billion	-43.39%
2023	-€0.3 Billion	-67.84%
2022	-€0.93 Billion	36.93%
2021	-€0.68 Billion	-8.04%
2020	-€0.74 Billion	-15.66%
2019	-€0.88 Billion	12.23%
2018	-€0.78 Billion	62.91%
2017	-€0.48 Billion	17.78%
2016	-€0.41 Billion	43.44%
2015	-€0.29 Billion	60.69%
2014	-€0.18 Billion	98.2%
2013	-€88.5 Million
2011	-€52.2 Million	27.48%
2010	-€40.95 Million	-10.92%
2009	-€45.97 Million	95.77%
2008	-€23.48 Million
2006	-€37.62 Million	-9.13%
2005	-€41.4 Million	34.74%
2004	-€30.73 Million	36.79%
2003	-€22.46 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Arrowhead Pharmaceuticals ARWR	-€0.56 Billion	210.42%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	€4.73 B	-2,759.15%	🇺🇸 USA
Sarepta Therapeutics SRPT	€0.12 B	-169.24%	🇺🇸 USA
OPKO Health OPK	-€0.12 Billion	-36.94%	🇺🇸 USA
Regulus Therapeutics RGLS	-€39.4 Million	-77.86%	🇺🇸 USA
Novartis NVS	€12.12 B	-6,912.96%	🇨🇭 Switzerland
Sanofi SNY	€7.05 B	-4,063.98%	🇫🇷 France
Teva Pharmaceutical Industries TEVA	€0.39 B	-324.74%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Alnylam Pharmaceuticals (ALNY)

Earnings in 2024 (TTM): -€0.17 Billion